153 related articles for article (PubMed ID: 11500608)
1. Does short-term treatment with proton pump inhibitors cause rebound aggravation of symptoms?
Farup PG; Juul-Hansen PH; Rydning A
J Clin Gastroenterol; 2001 Sep; 33(3):206-9. PubMed ID: 11500608
[TBL] [Abstract][Full Text] [Related]
2. Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease.
Richter JE; Campbell DR; Kahrilas PJ; Huang B; Fludas C
Arch Intern Med; 2000 Jun; 160(12):1803-9. PubMed ID: 10871974
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effect of lansoprazole and omeprazole on intragastric acidity and gastroesophageal reflux in patients with gastroesophageal reflux disease.
Janczewska I; Sagar M; Sjöstedt S; Hammarlund B; Iwarzon M; Seensalu R
Scand J Gastroenterol; 1998 Dec; 33(12):1239-43. PubMed ID: 9930385
[TBL] [Abstract][Full Text] [Related]
4. Speed of onset of oesophageal acid reduction with different proton-pump inhibitors in patients with reflux oesophagitis.
Newton M; Burnham WR; Kamm MA
Eur J Gastroenterol Hepatol; 1998 Sep; 10(9):753-8. PubMed ID: 9831269
[TBL] [Abstract][Full Text] [Related]
5. Management of heartburn in a large, randomized, community-based study: comparison of four therapeutic strategies.
Howden CW; Henning JM; Huang B; Lukasik N; Freston JW
Am J Gastroenterol; 2001 Jun; 96(6):1704-10. PubMed ID: 11419818
[TBL] [Abstract][Full Text] [Related]
6. Lansoprazole in the treatment of heartburn in patients without erosive oesophagitis.
Richter JE; Kovacs TO; Greski-Rose PA; Huang section sign B; Fisher R
Aliment Pharmacol Ther; 1999 Jun; 13(6):795-804. PubMed ID: 10383510
[TBL] [Abstract][Full Text] [Related]
7. Lansoprazole in the treatment of gastro-oesophageal reflux disease in childhood.
Franco MT; Salvia G; Terrin G; Spadaro R; De Rosa I; Iula VD; Cucchiara S
Dig Liver Dis; 2000 Nov; 32(8):660-6. PubMed ID: 11142573
[TBL] [Abstract][Full Text] [Related]
8. Treatment of patients with persistent heartburn symptoms: a double-blind, randomized trial.
Fass R; Sontag SJ; Traxler B; Sostek M
Clin Gastroenterol Hepatol; 2006 Jan; 4(1):50-6. PubMed ID: 16431305
[TBL] [Abstract][Full Text] [Related]
9. Omeprazole 40 mg once a day is equally effective as lansoprazole 30 mg twice a day in symptom control of patients with gastro-oesophageal reflux disease (GERD) who are resistant to conventional-dose lansoprazole therapy-a prospective, randomized, multi-centre study.
Fass R; Murthy U; Hayden CW; Malagon IB; Pulliam G; Wendel C; Kovacs TO
Aliment Pharmacol Ther; 2000 Dec; 14(12):1595-603. PubMed ID: 11121907
[TBL] [Abstract][Full Text] [Related]
10. Management of symptoms in step-down therapy of gastroesophageal reflux disease.
Mine S; Iida T; Tabata T; Kishikawa H; Tanaka Y
J Gastroenterol Hepatol; 2005 Sep; 20(9):1365-70. PubMed ID: 16105122
[TBL] [Abstract][Full Text] [Related]
11. High-dose proton-pump inhibitors as a diagnostic test of gastro-oesophageal reflux disease in endoscopic-negative patients.
Juul-Hansen P; Rydning A; Jacobsen CD; Hansen T
Scand J Gastroenterol; 2001 Aug; 36(8):806-10. PubMed ID: 11495074
[TBL] [Abstract][Full Text] [Related]
12. Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms.
Littner MR; Leung FW; Ballard ED; Huang B; Samra NK;
Chest; 2005 Sep; 128(3):1128-35. PubMed ID: 16162697
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of low-dose lansoprazole in the treatment of non-erosive gastrooesophageal reflux disease. Influence of infection by Helicobacter pylori.
Castro Fernández M; García Díaz E; Larraona JL; Rodríguez Hornillo MC; Lamas Rojas E; Núñez Hospital D; Pallarés Querol M
Rev Esp Enferm Dig; 2006 Mar; 98(3):170-9. PubMed ID: 16737416
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of omeprazole for the treatment of symptomatic acid reflux disease without esophagitis.
Richter JE; Peura D; Benjamin SB; Joelsson B; Whipple J
Arch Intern Med; 2000 Jun; 160(12):1810-6. PubMed ID: 10871975
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of the clinical implications of acid breakthrough in patients on proton pump inhibitor therapy.
Nzeako UC; Murray JA
Aliment Pharmacol Ther; 2002 Jul; 16(7):1309-16. PubMed ID: 12144581
[TBL] [Abstract][Full Text] [Related]
16. Control of intragastric pH with omeprazole 20 mg, omeprazole 40 mg and lansoprazole 30 mg.
Katz PO; Xue S; Castell DO
Aliment Pharmacol Ther; 2001 May; 15(5):647-52. PubMed ID: 11328258
[TBL] [Abstract][Full Text] [Related]
17. Ultrasonographic evaluation of lansoprazole-induced improvement of submucosal injury in patients with gastroesophageal reflux.
Mine S; Fujisaki T; Tabata T; Matsuoka H; Iida T; Yamada S; Tanaka Y; Morimoto I; Eto S; Aibe T
Am J Gastroenterol; 2000 Feb; 95(2):381-6. PubMed ID: 10685739
[TBL] [Abstract][Full Text] [Related]
18. Treatment of patients with heartburn without endoscopic evaluation: on-demand treatment after effective continuous administration of lansoprazole 15 mg.
Bigard MA; Genestin E
Aliment Pharmacol Ther; 2005 Oct; 22(7):635-43. PubMed ID: 16181303
[TBL] [Abstract][Full Text] [Related]
19. Effect of 7-day therapy with different doses of the proton pump inhibitor lansoprazole on the intragastric pH in healthy human subjects.
Harder H; Teyssen S; Stephan F; Pfützer R; Kiel G; Fuchs W; Singer MV
Scand J Gastroenterol; 1999 Jun; 34(6):551-61. PubMed ID: 10440603
[TBL] [Abstract][Full Text] [Related]
20. Gastro-oesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors.
Katz PO; Anderson C; Khoury R; Castell DO
Aliment Pharmacol Ther; 1998 Dec; 12(12):1231-4. PubMed ID: 9882031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]